Impaired functioning of the immune system against the background of viral and bacterial diseases contributes to the generalization of inflammatory processes, the development of complications, and asthenia. Immunomax is the recommended preparation for correcting immune disorders. The active ingredient is Acid Peptidoglycan from Potato Sprouts with a molecular weight of 1000-40,000 kD; Registration number: P N001919 / 02. Immunomax® stimulates the expression of genes of signaling receptors of immunity, which increases their sensitivity of immunocytes to pathogens of different nature and causes an adequate immune response in the body in the presence of the pathogen.

The analysis of the clinical and immunological effectiveness of the drug Immunomax® in the treatment of chronic diseases of bacterial, viral, or mixed etiology. Analysis of bibliographic systems shows an increase in publications devoted to the analysis of the clinical and immunological efficacy of the Immunomax® drug, which indicates the attention of researchers to this immunomodulator, the validity of its use in dysfunctions of factors of innate and adaptive immunity arising from bacterial and viral infections, secondary immunodeficiency states with impaired killer, phagocytic functions of secretory mechanisms, the process of generating and maintaining the balance of cytokines.